| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/25/2004 | CN1524073A Crystalline forms of 'r-(r*,r*)-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/25/2004 | CN1523992A Compositions and methods for treating amyloidosis |
| 08/25/2004 | CN1523990A Pharmaceutical composition for treating or improving arthritis and diet extender |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1522756A Chest bone fracture therapeutic oral medication |
| 08/25/2004 | CN1522745A Traditional Chinese medicine extract with anti-inflammatory action and promoting blood circulation function, and its preparation method |
| 08/25/2004 | CN1522739A Bone fracture analgesic ointment |
| 08/25/2004 | CN1522730A Rheumathritis capsule preparation method |
| 08/25/2004 | CN1522719A Pharmaceutical composition for treating rheumatism, rheumatoid arthritis and limb pains, and its preparation method |
| 08/25/2004 | CN1522717A Trauma treating medicament and method for making same |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163268C Preparation of oral collagen of gradient molecular weight |
| 08/25/2004 | CN1163262C Osteogenic growth peptide medicine composite and its preparation and application |
| 08/25/2004 | CN1163258C Medicine composite and its preparation |
| 08/25/2004 | CN1163255C Hyperosteogeny treating plaster |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780844 Calcium phosphopeptide complexes |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/19/2004 | WO2004070050A2 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069871A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069829A1 (2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis |
| 08/19/2004 | WO2004069820A1 Coumarin derivatives having an affinity for oestrogen receptors, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 08/19/2004 | WO2004069266A2 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
| 08/19/2004 | WO2004069257A1 Benzo (1,2,5) thiadiazole als crf-antagonisten |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2004056828A3 Novel compounds and uses thereof |
| 08/19/2004 | WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 08/19/2004 | WO2003025149A8 Cell populations which co-express cd49c and cd90 |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162430 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162415 growth and activity promotion effects on osteoblasts |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162304 Estrogen receptor modulators |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162247 Administering quercetin or at least one derivative for ameliorating the symptoms associated with osteoporosis |
| 08/19/2004 | US20040161478 Using plant extract as active material |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2515335A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | CA2513631A1 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | CA2512514A1 Benzo (1,2,5) thiadiazole als crf-antagonisten |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447086A1 An aqueous metal bicarbonate solution and method of use |
| 08/18/2004 | EP1447085A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446418A2 Integrin targeting compounds |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 08/18/2004 | EP1446382A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 08/18/2004 | EP1446381A1 Anthranilic acid amides and pharmaceutical use thereof |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446134A1 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors |
| 08/18/2004 | EP1446114A1 Compositions and methods for treating osteoporosis |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446112A1 USE OF GLUTAMATE, GLUTAMATE DERIVATIVES OR METABOLITES, GLUTAMATE ANALOGUES OR MIXTURES THEREOF FOR THE MANUFACTURE OF A COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/18/2004 | EP1257552B1 Xanthine derivatives, intermediates and use for treating osteoporosis |
| 08/18/2004 | EP1252170B1 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1079803B1 Protein formulations |
| 08/18/2004 | EP0909171B1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 08/18/2004 | EP0876345B1 Heterocyclic compounds as h+-atpases |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522254A Immunomodulating compounds |
| 08/18/2004 | CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1521189A Analogs of parathyroid hormone |
| 08/18/2004 | CN1520876A Externally used pharmaceutical for bone fracture |
| 08/18/2004 | CN1520875A Oral medication for bones injuries of brain |
| 08/18/2004 | CN1520874A Oral medication for bones injuries of neck |
| 08/18/2004 | CN1520873A Oral medication for bones injuries of limbs |
| 08/18/2004 | CN1520872A Oral medication for bones injuries of abdomen |
| 08/18/2004 | CN1520865A Medicament for osteoporosis and osteonecrosis |
| 08/18/2004 | CN1520854A Bone fracture therapeutic pharmaceuticals |
| 08/18/2004 | CN1520850A External use pharmaceutical liquid spray for traumatic injury |
| 08/18/2004 | CN1520849A Trauma pharmaceutical liquid spray |
| 08/18/2004 | CN1520830A High performance antiphlogistic drug pouch |